RegentAtlantic Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.16M | Sell |
29,939
-3,832
| -11% | -$148K | 0.03% | 283 |
|
|
2022
Q2 | $1.26M | Buy |
33,771
+283
| +0.8% | +$10.6K | 0.04% | 269 |
|
|
2022
Q1 | $1.48M | Sell |
33,488
-6,545
| -16% | -$290K | 0.04% | 261 |
|
|
2021
Q4 | $1.7M | Buy |
40,033
+7,847
| +24% | +$333K | 0.05% | 242 |
|
|
2021
Q3 | $1.4M | Buy |
32,186
+43
| +0.1% | +$1.87K | 0.04% | 253 |
|
|
2021
Q2 | $1.37M | Buy |
32,143
+4,630
| +17% | +$198K | 0.04% | 251 |
|
|
2021
Q1 | $1.06M | Buy |
27,513
+2,419
| +10% | +$93.5K | 0.04% | 269 |
|
|
2020
Q4 | $902K | Buy |
25,094
+3,175
| +14% | +$114K | 0.04% | 254 |
|
|
2020
Q3 | $838K | Buy |
21,919
+5,158
| +31% | +$197K | 0.04% | 256 |
|
|
2020
Q2 | $588K | Buy |
16,761
+7,690
| +85% | +$270K | 0.03% | 280 |
|
|
2020
Q1 | $296K | Buy |
+9,071
| New | +$296K | 0.02% | 333 |
|
|
2015
Q1 | – | Sell |
-445
| Closed | -$5.9K | – | 432 |
|
|
2014
Q4 | $5.9K | Buy |
+445
| New | +$5.9K | ﹤0.01% | 990 |
|